Skip to NavigationSkip to content

Pharmafile - Research and Development

Roche's risdiplam hits main goal in infants with spinal muscular atrophy
Roche has announced the success of its survival motor neuron-2 (SMN2) splicing modifier risdiplam in a new trial investigating its efficacy in the...
FDA fast-tracks GSK's multiple myeloma drug after priority review
The FDA has fast tracked GlaxoSmithKline (GSK) antibody drug conjugate (ADC) belantamab mafodotin, for the treatment of patients with refractory or...
Horizon's Tepezza becomes first and only FDA-approved drug for thyroid eye disorder
Horizon Therapeutics has announced that its IGF-1R inhibitor Tepezza (teprotumumab-trbw) has become the first and only therapy approved by the FDA...
Chinese coronavirus set to be put on international health emergency list
The World Health Organisation (WHO) is expected to trigger a Public Health Emergency over the Wuhan coronavirus outbreak, meaning it will join the...
>> More Research and Development News Stories

Features

Collaborating to realise the potential of precision medicine

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the industry...

>> More Features

Appointments

Ipsen appoints new Exec VP and Chief Medical Officer

Ipsen has named Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches